Industry News
Research, Science & Manufacturer Updates
Under a proposed rule by the Centers for Medicare and Medicaid Services(CMS), healthcare providers will have an extra year to use 2011 edition software in their electronic health record systems under the federal incentive program for health IT.
To evaluate the effect of intravenous immune globulin (IVIG) on cardiac rhythm and function in children younger than 12 years of age presenting with acute myocarditis and/or early dilated cardiomyopathy (DCM), investigators at a tertiary hospital in India conducted a retrospective analysis of case records between January 2010 and December 2012.
CSL Behring has enrolled its first patient in the pivotal pediatric PhaseIII study to evaluate the efficacy, safety and pharmacokinetics of its novel investigational recombinant factor VIII single chain (rVIII-SingleChain) for the treatment of previously treated children (up to 11 years) with severe hemophilia A.
The National Institutes of Health began human testing of an ebola vaccine in a Phase I clinical trial in September.
The Centers for Disease Control and Prevention found that vaccination coverage among adolescents ages 13 to 17 years rose between 2012 and 2013.
Thirty-nine recipients from 27 states and the District of Columbia have been chosen by the Department of Health andHuman Services to receive Health CareInnovation Awards that total as much as$360 million to test care models designed to deliver better healthcare and lower costs.
The Centers for Disease Control andPrevention (CDC) has released the nation’s numbers for the 2013-2014 influenza season, which show Americans were hit particularly hard due to the return of the H1N1 virus that caused the 2009 swine flu pandemic.
A new piece of legislation aims to stop prescription drug abuse by mandating that drugmakers registered under the Controlled Substances Act conduct background checks and perform employee drug testing for those with access to controlled substances.
Prophylactic treatment with an anti-inhibitor coagulant complex (FEIBA NF [Factor Eight Inhibitor Bypassing Activity], Baxter Healthcare) reduced the median annualized bleeding rate (ABR) more than three-fold as compared with on-demand treatment with the product to control acute hemorrhages, according to a Phase III study of 36 subjects with hemophilia A or B and inhibitory alloantibodies to factor VIII or factor IX.
The U.S. Department of Health and Human Services Office of Research Integrity (ORI) and Office for Human Research Protections (OHRP) released a web-based training video known as “The Research Clinic” to help teach clinical and social researchers how to better protect research subjects and avoid research misconduct.
Experimental and clinical data show that, compared with crystalloids, colloid fluid therapy mediates multiple beneficial effects in the lungs of patients suffering from acute respiratory distress
syndrome (ARDS), including reduced alveolar-capillary permeability, reduced histological damage, reduced inflammatory cell infiltration and faster hemodynamic stabilization.
The Centers for Medicare and MedicaidServices’ 2015 rate announcement and final call letter for Medicare Advantage and Part D programs implements several policies that will ensure beneficiaries have access to high-quality, high-value and low-cost options.